Lesia M Ruglass1, Santiago Papini1, Leora Trub2, Denise A Hien3. 1. The City College of New York of CUNY, USA. 2. Pace University, USA. 3. The City College of New York of CUNY, USA ; Columbia University College of Physicians and Surgeons, USA.
Abstract
OBJECTIVE: The use of psychometrically sound measures to assess and monitor PTSD treatment response over time is critical for better understanding the relationship between PTSD symptoms and Substance Use Disorder (SUD) symptoms throughout treatment. We examined the psychometric properties of the Modified Posttraumatic Stress Disorder (PTSD) Symptom Scale, Self-Report (MPSS-SR). METHODS: Three hundred fifty three women diagnosed with co-occurring PTSD (full or sub-threshold) and SUD who participated in a multisite treatment trial completed the MPSS-SR at pre-treatment, weekly during treatment, and posttreatment. Reliability and validity analyses were applied to the data. RESULTS: Internal consistency was excellent throughout the course of the trial demonstrating the MPSS-SR's high reliability. Strong correlations between MPSS-SR scores and the Brief Symptom Inventory and the Clinician Administered PTSD Scale (CAPS) severity scores demonstrated the MPSS-SR's convergent and concurrent validity. We conducted a classification analysis at posttreatment and compared the MPSS-SR at various cutoff scores with the CAPS diagnosis. A cutoff score of 29 on the MPSS-SR yielded a sensitivity rate of 89%, a specificity rate of 77%, and an overall classification rate of 80%, indicating the measure's robust ability to accurately identify individuals with PTSD in our sample at posttreatment. CONCLUSIONS: Findings support the use of the MPSS-SR as a reliable and valid tool to assess and monitor changes in PTSD symptoms over the course of treatment and as an alternative to structured clinical interviews to assess PTSD symptoms among populations with SUDs.
OBJECTIVE: The use of psychometrically sound measures to assess and monitor PTSD treatment response over time is critical for better understanding the relationship between PTSD symptoms and Substance Use Disorder (SUD) symptoms throughout treatment. We examined the psychometric properties of the Modified Posttraumatic Stress Disorder (PTSD) Symptom Scale, Self-Report (MPSS-SR). METHODS: Three hundred fifty three women diagnosed with co-occurring PTSD (full or sub-threshold) and SUD who participated in a multisite treatment trial completed the MPSS-SR at pre-treatment, weekly during treatment, and posttreatment. Reliability and validity analyses were applied to the data. RESULTS: Internal consistency was excellent throughout the course of the trial demonstrating the MPSS-SR's high reliability. Strong correlations between MPSS-SR scores and the Brief Symptom Inventory and the Clinician Administered PTSD Scale (CAPS) severity scores demonstrated the MPSS-SR's convergent and concurrent validity. We conducted a classification analysis at posttreatment and compared the MPSS-SR at various cutoff scores with the CAPS diagnosis. A cutoff score of 29 on the MPSS-SR yielded a sensitivity rate of 89%, a specificity rate of 77%, and an overall classification rate of 80%, indicating the measure's robust ability to accurately identify individuals with PTSD in our sample at posttreatment. CONCLUSIONS: Findings support the use of the MPSS-SR as a reliable and valid tool to assess and monitor changes in PTSD symptoms over the course of treatment and as an alternative to structured clinical interviews to assess PTSD symptoms among populations with SUDs.
Entities:
Keywords:
PTSD; Reliability; Substance use disorders; Trauma; Treatment outcomes; Validity
Authors: Denise A Hien; Huiping Jiang; Aimee N C Campbell; Mei-Chen Hu; Gloria M Miele; Lisa R Cohen; Gregory S Brigham; Carrie Capstick; Agatha Kulaga; James Robinson; Lourdes Suarez-Morales; Edward V Nunes Journal: Am J Psychiatry Date: 2009-11-16 Impact factor: 18.112
Authors: Denise A Hien; Kathryn Z Smith; Max Owens; Teresa López-Castro; Lesia M Ruglass; Santiago Papini Journal: J Consult Clin Psychol Date: 2018-10
Authors: Lesia M Ruglass; Teresa Lopez-Castro; Santiago Papini; Therese Killeen; Sudie E Back; Denise A Hien Journal: Psychother Psychosom Date: 2017-05-11 Impact factor: 17.659
Authors: Samantha C Holmes; Laura Callinan; Vanessa C Facemire; Monnica T Williams; Maria M Ciarleglio; Megan V Smith Journal: J Trauma Stress Date: 2021-10-13
Authors: Lesia M Ruglass; Antonio A Morgan-López; Lissette M Saavedra; Denise A Hien; Skye Fitzpatrick; Therese K Killeen; Sudie E Back; Teresa López-Castro Journal: Psychol Assess Date: 2020-08-27
Authors: Kristen Nishimi; Karmel W Choi; Janine Cerutti; Abigail Powers; Bekh Bradley; Erin C Dunn Journal: Psychol Med Date: 2020-05-14 Impact factor: 7.723
Authors: Lesia M Ruglass; Alina Shevorykin; Vanja Radoncic; Kathryn M Z Smith; Philip H Smith; Isaac R Galatzer-Levy; Santiago Papini; Denise A Hien Journal: J Clin Med Date: 2017-02-07 Impact factor: 4.241